Human Papillomavirus 16/18–Associated Cervical Lesions: Differences by Area-Based Measures of Race and Poverty

• Published in: American journal of preventive medicine Vol. 58; no. 5; pp. e149 - e157
• Main Authors: Brackney, Monica M., Gargano, Julia W., Hannagan, Susan E., Meek, James, Querec, Troy D., Niccolai, Linda M.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01-05-2020
• Subjects: Adult; Connecticut; Continental Population Groups; Female; Human papillomavirus 16 - isolation & purification; Human papillomavirus 18 - isolation & purification; Humans; Longitudinal Studies; Papillomavirus Infections - diagnosis; Papillomavirus Infections - ethnology; Papillomavirus Vaccines - administration & dosage; Poverty - ethnology; Poverty - trends; Uterine Cervical Neoplasms - prevention & control; Young Adult; Connecticut
• ISSN: 0749-3797; 1873-2607
• DOI: 10.1016/j.amepre.2019.12.003

This analysis evaluates trends in cervical lesions with human papillomavirus 16/18 detected by area-based measures of race, ethnicity, and poverty during 2008–2015.
Trends in the proportion of lesions with human papillomavirus 16/18 detected among residents of New Haven County, Connecticut were examined by area-based measures of race, ethnicity, and poverty. Area-based measures are aggregate descriptors of census tract characteristics useful for measuring differences in health outcomes in the context of where people live. Multivariable logistic regression modeling was conducted, adjusted for individual-level race, ethnicity, and insurance status to assess the independent effects of area-based measures. Data were analyzed in 2018–2019.
Among women aged 21–24 years and 25–29 years, significant declines in the proportion of lesions with human papillomavirus 16/18 were observed. Among women aged 21–24 years, declines began earlier and were greater in magnitude in areas of lower poverty (OR=0.55, 95% CI=0.36, 0.85 for 2010–2012 vs 2008–2009 and OR=0.30, 95% CI=0.18, 0.51 for 2013–2015 vs 2008–2009) compared with higher poverty (OR=1.66, 95% CI=0.86, 3.21 and OR=0.48, 95% CI=0.19, 1.20). Similar patterns were observed for women aged 25–29 years, and for area-based measures of race and ethnicity.
Differences were observed in declines in the proportion of human papillomavirus 16/18 lesions by area-based measures since the introduction of human papillomavirus vaccines, with greater and earlier declines in areas with fewer residents living in poverty and racial minorities. Ongoing human papillomavirus vaccine impact monitoring is necessary to track differences by sociodemographic characteristics.